All filters
Slidesets
Occult Hepatitis B Virus Infection in isolated anti-HBc individuals in Eastern Ethiopia - Desalegn Admassu
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Seroprevalence and associated risks factors for Hepatitis B virus infection among barbers and thei - Ngoupa Joel
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
The Effect of COVID-19 on the Hepatitis C Screening in Georgia - Ana Aslanikashvili
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
The Impact of COVID-19 on Hepatitis Elimination (Health Care Perspective) - Saeed Hamid
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Reduction of Hepatitis C Burden in Islamabad, Pakistan Slums Through CHW Screen and Treat Programs - Hassan Mahmood
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Toward Hepatitis B and hepatitis D elimination in Cuba
L. Lay Rodriguez  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Occult Hepatitis B Virus Infection among HIV negative and positive isolated anti-HBc individuals in Eastern Ethiopia
D. Ayana  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Healthcare consumption in addicted versus non-addicted hepatitis B and C patients in the Netherlands
D. Von Den Hoff Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence and associated risk factors for Hepatitis B virus infection among barbers and their clients in two cities of Cameroon
N. Joël Brice Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA seroconversion and genetically linked HCV infections
P. Mateu-Gelabert  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Cost Effectiveness of expanding treatment with Direct Acting Antiviral treatment to reduce Hepatitis C incidence among HIV infected MSM in Thailand
S. Mukherjee Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Missed Opportunities for HCV Elimination in Provincial Correctional Institutions in Ontario, Canada
P. Ioudovski Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Reduction of hepatitis C burden in Islamabad, Pakistan slums through CHW screen and treat programs
H. Mahmood  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
HCV elimination in France. The countdown has started
V. de Ledinghen  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Models of Care: Strategies towards Elimination of Hepatitis C in Iceland
R. Fridriksdottir  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
The TREAT-B score predicts disease progression in Ethiopian patients with chronic hepatitis B
A. Johannessen Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Expression of HBV-infection markers in placenta of women with chronic hepatitis B
M. Belopolskaia  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Eliminating hepatitis B virus infection in west African migrants living in Barcelona: a community-based testing and vaccination model of care to link patients to liver specialists
C. Picchio Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Enabling HCV scale up through the introduction of a simplified testing approach in Delhi: The HEAD-Start project
D. Soni Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Changes in hepatic fibrosis stages after achieving SVR following direct acting antiviral treatment in children with chronic hepatitis C
R. Soliman Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
External validation of GES score to predict HCC risk in patients with HCV associated significant hepatic fibrosis following DAAs in genotype 1 and 2 in Japan.
G. Shiha Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Decentralized testing and treatment of hepatitis C in people who inject drugs– the Shared Addiction Care Copenhagen (SACC) project
C. Sølund Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
A novel hepatitis C intervention in Denmark to test and treat people who inject drugs
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Collocating Hepatitis C Care at Syringe Exchange Programs: Hepatitis C treatment with Less Stigma.
Y. Aponte-Melendez Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020